Private equity firm Apax Partners is continuing to keep the medical aesthetics market space hot with its proposed acquisition of Syneron Medical Ltd., also known as Syneron Candela, for $397 million. The acquisition price represents a 15 percent premium to the Yokne'am Illit, Israel-based company's 90-day average closing price through Feb. 10. News of the deal caused Syneron's shares (NASDAQ:ELOS) to rise as high as 6.9 percent during Monday trade. Shares closed at $11.10 up about 5.2 percent. The Syneron board unanimously approved the transaction. Shimon Eckhouse, who owns 7.4 percent of the company, has...
Private equity firm Apax Partners is continuing to keep the medical aesthetics market space hot with its proposed acquisition of Syneron Medical Ltd., also known as Syneron Candela, for $397 million. The acquisition price represents a 15 percent premium to the Yokne'am Illit, Israel-based company's 90-day average closing price through Feb. 10. News of the deal caused Syneron's shares (NASDAQ:ELOS) to rise as high as 6.9 percent during Monday trade. Shares closed at $11.10 up about 5.2 percent.
Endologix Inc. is on a path to expanding its Ovation platform through its ELEVATE IDE clinical study. The Irvine, Calif.-based company said the 75-patient trial will evaluate the safety and effectiveness of its Ovation Alto abdominal stent graft system for the repair of infrarenal abdominal aortic aneurysms (AAA). The company said the first patients have already been treated in the trial. Ovation Alto broadens Endologix's reach into the endovascular aortic repair (EVAR) market and provides treatment options for patients with complex AAAs. The device is specifically targeted toward patients with very short or otherwise challenging...
Endologix Inc. is on a path to expanding its Ovation platform through its ELEVATE IDE clinical study. The Irvine, Calif.-based company said the 75-patient trial will evaluate the safety and effectiveness of its Ovation Alto abdominal stent graft system for the repair of infrarenal abdominal aortic aneurysms (AAA). The company said the first patients have already been treated in the trial.
Organogenesis Inc. is set to acquire Nutech Medical Inc. a private company and supplier of tissue products used in spinal and orthopedic surgeries. Financial details surrounding the deal were not disclosed. Canton, Mass.-based Organogenesis has been waiting to enter the amniotic tissue market, which led to it picking up Nutech Medical. "The acquisition expands Organogenesis' product profile into the surgical, orthopedic, spine and amniotic wound care markets and unites two pioneering companies, each with decades of experience in bringing quality biologics products to patients around the world," Gary Gillheeney, president and CEO of Organogenesis, told...
Organogenesis Inc. is set to acquire Nutech Medical Inc. a private company and supplier of tissue products used in spinal and orthopedic surgeries. Financial details surrounding the deal were not disclosed.
Newly published guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) support cardiac monitoring devices in evaluating syncope patients. The "2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope" was recently published online in the Journal of the American College of Cardiology, Circulation and Heartrhythm. American College of Emergency Physicians and the Society for Academic Emergency Medicine also helped draft the guidelines. The new measures point out the choice of a specific cardiac monitor should be determined on the basis of the...
Newly published guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) support cardiac monitoring devices in evaluating syncope patients.
Biostable Science & Engineering Inc. received FDA clearance for its Haart 300 product, an annuloplasty device designed for aortic valve repair. The Austin, Texas-based company said it will launch the device in select heart centers this summer. The company has had CE mark for the Haart 300 since March 2016. (See Medical Device Daily, March 9, 2016.) Heart valve repair is a procedure to repair native valve function instead of replacing it with a mechanical or biological replacement device. Valve repair may be more durable than biological valve replacement and avoids the complications associated with...
